Jump to content

Contingent value rights: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
restoring material with refs.
 
(14 intermediate revisions by 6 users not shown)
Line 2: Line 2:
In [[corporate finance]],
In [[corporate finance]],
'''Contingent Value Rights''' (CVR) are [[Contractual rights|rights]] granted by an [[Mergers and acquisitions |acquirer]] to a company’s [[shareholders]], <ref>[[Investopedia]] (2020). [http://www.investopedia.com/terms/c/cvr.asp ''Contingent Value Right (CVR)'']</ref> facilitating the transaction where some uncertainty is inherent.
'''Contingent Value Rights''' (CVR) are [[Contractual rights|rights]] granted by an [[Mergers and acquisitions |acquirer]] to a company’s [[shareholders]], <ref>[[Investopedia]] (2020). [http://www.investopedia.com/terms/c/cvr.asp ''Contingent Value Right (CVR)'']</ref> facilitating the transaction where some uncertainty is inherent.
CVRs may be separately tradeable [[Security (finance)| securities]]; they are occasionally acquired (or [[short (finance)|shorted]]) by specialized [[hedge fund]]s.
CVRs may be separately [[tradeable securities]]; <ref name="Fool"/>
they are occasionally acquired (or [[short (finance)|shorted]]) by specialized [[hedge fund]]s. <ref>See for example [https://www.sec.gov/Archives/edgar/data/1518042/000158064218000407/baltermergeropp_485a.htm this] [[Prospectus (finance)|prospectus]] as filed with the [[U.S. Securities and Exchange Commission|SEC]].</ref>


==Forms==
==Forms==
These rights typically take either of two forms:<ref>[[Thomson Reuters]] (2019). [http://www.wlrk.com/webdocs/wlrknew/AttorneyPubs/WLRK.26465.19.pdf ''Contingent Value Rights (CVRs)''], Practical Law series</ref>
These rights typically take either of two forms:<ref>[[Thomson Reuters]] (2019). [http://www.wlrk.com/webdocs/wlrknew/AttorneyPubs/WLRK.26465.19.pdf ''Contingent Value Rights (CVRs)''], Practical Law series</ref>
(1) Event-driven CVRs compensate the owners for yet to eventuate positive developments in their business - hence also protecting the acquirer against [[valuation risk]].
(1) Event-driven CVRs compensate the owners for yet to eventuate positive developments in their business - hence protecting the acquirer against the [[valuation risk]] inherent in overpaying.
(2) Price-protection CVRs are granted when [[Mergers_and_acquisitions#Stock |payment is share based]], providing a [[hedge (finance)|hedge]] against downside [[price risk]] in the acquirer's equity. <ref name="Chatterjee"/>
(2) Price-protection CVRs are granted when [[Mergers_and_acquisitions#Stock |payment is share based]] - protecting the acquired company, by providing a [[hedge (finance)|hedge]] against downside [[price risk]] in the acquirer's equity. <ref name="Chatterjee"/>


In the first case, CVRs are granted
In the first case, CVRs are granted
<ref>[[Motley Fool]] (2018). [https://www.fool.com/investing/2018/10/19/what-is-a-contingent-value-right.aspx ''What Is a Contingent Value Right?'']</ref>
<ref name="Fool">[[Motley Fool]] (2018). [https://www.fool.com/investing/2018/10/19/what-is-a-contingent-value-right.aspx ''What Is a Contingent Value Right?'']</ref>
in scenarios in which the acquiring company does not wish to pay for a product that might not work, has a limited market, or might need significant investment;
in scenarios in which the acquiring company does not wish to pay for a product that might not work, has a limited market, or might need significant investment;
whereas on the other side, the acquired company “wants to get full value for its assets”.
whereas on the other side, the acquired company “wants to get full value for its assets”.
Line 17: Line 18:
- one where the value of the firm significantly increases
- one where the value of the firm significantly increases
- within a specified timeframe.
- within a specified timeframe.
CVRs are very common in the [[:Category:Life sciences industry |biotech]] and [[Pharmaceutical industry |pharmaceutical industries]]; they are also often granted to shareholders in companies facing significant, [[Accretion (finance) |value accretive]] restructuring.
CVRs are common in the [[:Category:Life sciences industry |biotech]] and [[Pharmaceutical industry |pharmaceutical industries]]
(see {{slink|Valuation (finance)#Valuation of intangible assets}});
they are also often granted to shareholders in companies facing significant, [[Accretion (finance) |value accretive]] restructuring.
For an example see [[Media General]] / [[Nexstar Media Group]].
For an example see [[Media General]] / [[Nexstar Media Group]].


The second case, protection against price risk, is facilitated by specifying that payment will be made at an averaged, as opposed to final, share price; a floor may also be set. <ref>[[U.S. Securities and Exchange Commission|SEC]] (2006). [https://www.sec.gov/Archives/edgar/data/1094961/000119312506126810/dex991.htm ''Questions and Answers For Contingent Value Rights Holders'']</ref>
In the second case, protection against price risk is facilitated by specifying that payment will be made at an averaged, as opposed to final, share price; a floor may also be set. <ref>[[U.S. Securities and Exchange Commission|SEC]] (2006). [https://www.sec.gov/Archives/edgar/data/1094961/000119312506126810/dex991.htm ''Questions and Answers For Contingent Value Rights Holders'']</ref>


==Valuation==
==Valuation==
Under both, the CVR is in function, a form of [[Option (finance)|option]].
Under both, the CVR is in function, a form of [[Option (finance)|option]].
<ref>Jan W Dash (2004). [https://books.google.co.za/books/about/Quantitative_Finance_and_Risk_Management.html?id=wGVIDQAAQBAJ&redir_esc=y ''Quantitative Finance and Risk Management: A Physicist's Approach''], World Scientific. {{ISBN|978-9812387127}}</ref>
<ref>Jan W Dash (2004). [https://books.google.com/books?id=wGVIDQAAQBAJ ''Quantitative Finance and Risk Management: A Physicist's Approach''], World Scientific. {{ISBN|978-9812387127}}</ref>


The first case: analogous to a [[call option]], the payout to the CVR holder will be triggered by the event occurring, and will be zero otherwise.
The first case: analogous to a [[call option]], the payout to the CVR holder will be triggered by the event occurring, and will be zero otherwise.
To [[valuation (finance)|determine the value]] of these rights,
To [[valuation (finance)|determine the value]] of these rights,
analysts will apply a modified [[option pricing]] model based on the probability of the event, the time horizon specified, and the corresponding payout rules;
analysts will apply a modified [[option pricing]] model based on the probability of the event, the time horizon specified, and the corresponding payout rules;
see [[contingent claim valuation]].
see [[Contingent claim valuation]], [[Real options valuation]], and {{slink|Mergers and acquisitions#Business valuation}}.
<ref>[[Aswath Damodaran]] (ND). [http://pages.stern.nyu.edu/~adamodar/New_Home_Page/lectures/approach.html ''Valuation: Approaches & Discounted Cash Flow Models'']</ref>
<ref>[[Aswath Damodaran]] (ND). [http://pages.stern.nyu.edu/~adamodar/New_Home_Page/lectures/approach.html ''Valuation: Approaches & Discounted Cash Flow Models'']</ref>


The second: the CVR takes the form of a modified [[Asian option]].<ref name="Chatterjee">Sris Chatterjee (2003). [http://papers.ssrn.com/sol3/papers.cfm?abstract_id=424903 ''Contingent Value Rights in Acquisitions: Theory and Empirical Evidence''], EFA 2003 Annual Conference Paper No. 897</ref>
The second: the CVR takes the form of a modified [[Asian option]].<ref name="Chatterjee">Sris Chatterjee (2003). [https://ssrn.com/abstract=424903 ''Contingent Value Rights in Acquisitions: Theory and Empirical Evidence''], EFA 2003 Annual Conference Paper No. 897</ref>

==References==
{{reflist}}


==See also==
==See also==
*[[Strip financing]]
*[[Strip financing]]
*[[Hold-up problem]]
*[[Hold-up problem]]
*[[Earnout]]

==References==
{{reflist}}


==External links==
==External links==
Line 46: Line 50:
*[https://www.forbes.com/sites/greatspeculations/2011/05/09/shadowy-shares-the-dark-side-of-contingent-value-rights/#425e23603343 Shadowy Shares: The Dark Side of Contingent Value Rights, Forbes.com] (Michael Stocker, Iona Evan. 2011)
*[https://www.forbes.com/sites/greatspeculations/2011/05/09/shadowy-shares-the-dark-side-of-contingent-value-rights/#425e23603343 Shadowy Shares: The Dark Side of Contingent Value Rights, Forbes.com] (Michael Stocker, Iona Evan. 2011)


{{Corporate finance and investment banking}}
[[Category:Corporate finance]]
[[Category:Corporate finance]]
[[Category:Mergers and acquisitions]]
[[Category:Mergers and acquisitions]]
Line 52: Line 57:
[[Category:Real options]]
[[Category:Real options]]
[[Category:Equity securities]]
[[Category:Equity securities]]
[[Category:Venture capital]]

Latest revision as of 10:54, 22 August 2023

In corporate finance, Contingent Value Rights (CVR) are rights granted by an acquirer to a company’s shareholders, [1] facilitating the transaction where some uncertainty is inherent. CVRs may be separately tradeable securities; [2] they are occasionally acquired (or shorted) by specialized hedge funds. [3]

Forms

[edit]

These rights typically take either of two forms:[4] (1) Event-driven CVRs compensate the owners for yet to eventuate positive developments in their business - hence protecting the acquirer against the valuation risk inherent in overpaying. (2) Price-protection CVRs are granted when payment is share based - protecting the acquired company, by providing a hedge against downside price risk in the acquirer's equity. [5]

In the first case, CVRs are granted [2] in scenarios in which the acquiring company does not wish to pay for a product that might not work, has a limited market, or might need significant investment; whereas on the other side, the acquired company “wants to get full value for its assets”. The CVR then “helps bridge this negotiation”. Under these rights, shareholders will receive additional cash, securities, or benefits if a specific and named event occurs - one where the value of the firm significantly increases - within a specified timeframe. CVRs are common in the biotech and pharmaceutical industries (see Valuation (finance) § Valuation of intangible assets); they are also often granted to shareholders in companies facing significant, value accretive restructuring. For an example see Media General / Nexstar Media Group.

In the second case, protection against price risk is facilitated by specifying that payment will be made at an averaged, as opposed to final, share price; a floor may also be set. [6]

Valuation

[edit]

Under both, the CVR is in function, a form of option. [7]

The first case: analogous to a call option, the payout to the CVR holder will be triggered by the event occurring, and will be zero otherwise. To determine the value of these rights, analysts will apply a modified option pricing model based on the probability of the event, the time horizon specified, and the corresponding payout rules; see Contingent claim valuation, Real options valuation, and Mergers and acquisitions § Business valuation. [8]

The second: the CVR takes the form of a modified Asian option.[5]

See also

[edit]

References

[edit]
  1. ^ Investopedia (2020). Contingent Value Right (CVR)
  2. ^ a b Motley Fool (2018). What Is a Contingent Value Right?
  3. ^ See for example this prospectus as filed with the SEC.
  4. ^ Thomson Reuters (2019). Contingent Value Rights (CVRs), Practical Law series
  5. ^ a b Sris Chatterjee (2003). Contingent Value Rights in Acquisitions: Theory and Empirical Evidence, EFA 2003 Annual Conference Paper No. 897
  6. ^ SEC (2006). Questions and Answers For Contingent Value Rights Holders
  7. ^ Jan W Dash (2004). Quantitative Finance and Risk Management: A Physicist's Approach, World Scientific. ISBN 978-9812387127
  8. ^ Aswath Damodaran (ND). Valuation: Approaches & Discounted Cash Flow Models
[edit]